Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

Clinical trial NCT07012447 · RECRUITING

Trial details

NCT number: NCT07012447
Sponsor: yuejun Liu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early T Acute Lymphoblastic Leukemia T-Acute Lymphoblastic Leukemia Mixed Phenotype Acute Leukemia, T/Myeloid, Nos

Start date: 2025-04-01
Primary completion: 2027-04-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.